Complete Bibliography

Visit PubMed to see Dr. Steve Pergam's complete publications record.


Selected Publications

Understanding risk factors and outcomes of cancer and transplant patients with community and hospital-acquired diarrheal pathogens

Boyle NM, Podczervinski S, Jordan K, Stednick Z, Butler-Wu SM, McMillen K, Pergam SA. Bacterial Foodborne Infections After Hematopoietic Cell Transplantation.  Biol Blood Marrow Transplant. 2014 2014 Nov;20(11):1856-61. PMCID: 4194273.

Boyle NM, Magaret A, Stednick Z, Morrison A, Butler-Wu S, Zerr D, Rogers K, Podczervinski S, Cheng A, Wald A, Pergam SA. Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients. Antimicrob Resist Infect Control. 2015 Oct 14;4:41. doi: 10.1186/s13756-015-0081-4. eCollection 2015. PMCID: PMC4606905.

Cohen S, Woodfield M, Boyle N, Stednick Z, Boeckh M, Pergam SA. Incidence and Outcomes of Bloodstream Infections among Hematopoietic Cell Transplant Recipients from Species Commonly Reported to be in Over-the-Counter Probiotic FormulationsTranspl Infect Dis. 2016 Aug 8. doi: 10.1111/tid.12587. [Epub ahead of print]. PMCID: PMC5160044.

Establishing risk of cytomegalovirus (CMV) in identifiable subsets of allogeneic transplant recipients

†Milano F, †Pergam SA, Xie H, Leisenring WM, Gutman JA, Riffkin I, Chow V, Boeckh MJ, Delaney C. Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipientsBlood. 2011 Nov 17;118(20):5689-96. PMCID: 3217367. († = contributed equally)

Pergam SA, Xie H, Sandhu R, Pollack M, Smith J, Stevens-Ayers T, Ilieva V, Kimball LE, Huang ML, Hayes TS, Corey L, Boeckh MJ. Risk factors and efficiency of CMV transmission in seronegative hematopoietic stem cell recipientsBiol Blood Marrow Transplant. 2012 Sep;18(9):1391-400. PMCID: 3572857.

Understanding the risk of drug resistance and healthcare-associated infections in cancer patients undergoing chemotherapy and hematopoietic cell transplant (HCT)

Miles-Jay A, Butler-Wu S, Rowhani-Rahbar A, Pergam SA. Incidence rate of fluoroquinolone resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplant patients during an era of levofloxacin prophylaxis. Biol Blood Marrow Transplant. 2015 Mar;21(3):539-45. PMID: 25498393; PMCID: PMC4329069.

Miles-Jay A, Podczervinski S, Stednick ZJ, Pergam SA. Evaluation of routine pretransplanation screening for methicillin-resistant Staphylococcus aureus in hematopoietic cell transplant recipients. Am J Infect Control. 2015 Jan;43(1):89-91. PMCID: PMC4286793.

Addressing novel methods for the prevention of respiratory viruses in high-risk immunosuppressed hosts

Chu HY, Englund JA, Podczervinski S, Kuypers J, Campbell AP, Boeckh MJ, Pergam SA, Casper C. Nosocomial transmission of respiratory syncytial virus in an outpatient cancer centerBiol Blood Marrow Transplant. 2014 Jun;20(6):844-51. PMCID: 4036533.

Podczervinski S, Stednick Z, Helbert L, Davies J, Jagels B, Gooley T, Casper C, Pergam SA. Comparison of “Carrot-vs.-Stick” approaches to employee influenza vaccination in a large cancer center with high baseline compliance ratesAm J Infect Control. 2015 Mar 1;43(3):228-33. PMCID: PMC4372134.

Waghmare A, Pergam SA, Jerome KR, Englund JA, Boeckh M, Kuypers J. Clinical disease due to enterovirus D68 in adult hematologic malignancy patients and hematopoietic cell transplant recipientsBlood. 2015 Mar 12;125(11):1724-9. PMCID: PMC4357580.